AlTi Global, Inc.

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1838615 NEW YORK, NY

Position in RLMD

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$222,546

+$68,107 QoQ

Shares Held

31,975

0.0% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AlTi Global, Inc. holds $5,270,139 across 9 Biotechnology names. RLMD ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,857	$1,434,792
2	RPRX	Royalty Pharma plc	25,073	$1,202,751
3	MDGL	Madrigal Pharmaceuticals, Inc.	1,492	$781,017
4	CELC	Celcuity Inc.	5,287	$603,458
5	MDXG	Mimedx Group, Inc.	95,212	$376,087
6	VRTX	Vertex Pharmaceuticals Inc / Ma	673	$300,520
7	RLMD	Relmada Therapeutics, Inc. This page	31,975	$222,546
8	MRNA	Moderna, Inc.	4,220	$214,375

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$222,546	31,975	0.0%	Shares	Defined	2026-05-07
2025-12-31	$154,439	31,975	0.0%	Shares	Defined	2026-02-13
2025-09-30	$64,269	31,975	0.0%	Shares	Defined	2025-11-06
2025-06-30	$19,185	31,975	0.0%	Shares	Defined	2025-07-31
2025-03-31	$8,633	31,975	0.0%	Shares	Defined	2025-05-15
2024-12-31	$16,627	31,975	0.0%	Shares	Defined	2025-02-14
2024-09-30	$103,599	31,975	0.0%	Shares	Defined	2024-11-14
2024-06-30	$95,925	31,975	0.0%	Shares	Defined	2024-08-14
2024-03-31	$148,683	31,975	+0.8%	Shares	Defined	2024-05-15
2023-12-31	$131,300	31,715	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.